Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

Erik O. Pettersen*, Peter Ebbesen, Roben G. Gieling, Kaye J. Williams, Ludwig Dubois, Philippe Lambin, Carol Ward, James Meehan, Ian H. Kunkler, Simon P. Langdon, Anne H. Ree, Kjersti Flatmark, Heidi Lyng, Maria J. Calzada, Luis del Peso, Manuel O. Landazuri, Agnes Goerlach, Hubert Flamm, Jochen Kieninger, Gerald UrbanAndreas Weltin, Dean C. Singleton, Syed Haider, Francesca M. Buffa, Adrian L. Harris, Andrea Scozzafava, Claudiu T. Supuran, Isabella Moser, Gerhard Jobst, Morten Busk, Kasper Toustrup, Jens Overgaard, Jan Alsner, Jacques Pouyssegur, Johanna Chiche, Nathalie Mazure, Ibtissam Marchiq, Scott Parks, Afshan Ahmed, Margaret Ashcroft, Silvia Pastorekova, Yihai Cao, Kasper M. Rouschop, Brad G. Wouters, Marianne Koritzinsky, Hilda Mujcic, Dan Cojocari

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

73 Citations (Web of Science)
Original languageEnglish
Pages (from-to)689-721
JournalJournal of Enzyme Inhibition and Medicinal Chemistry
Issue number5
Publication statusPublished - 2015


  • Bioreductive compounds
  • cancer-treatment resistance
  • carbonic anhydrase inhibitors
  • dual-activity compounds
  • non-invasive oxygen detection
  • targets for new treatment

Cite this